China Dishes Out First Aerosol COVID-19 Boosters Amid New Wuhan Lockdown 26/10/2022 Kerry Cullinan China administered the world’s first oral aerosol COVID-19 vaccine boosters in Shanghai on Wednesday, as new lockdown measures were imposed on Wuhan, the supposed birthplace of the pandemic. Chinese vaccine manufacturer CanSino Biologics said in a media statement that the inclusion of its vaccine in Shanghai’s booster vaccination program marked “the start of the rollout […] Continue reading -> Countries Fail to Promote Physical Activity; Study Links Exercise and Vaccine Efficacy 25/10/2022 Kerry Cullinan Most countries are failing dismally to promote physical exercise despite inactivity playing a major role in heart disease, obesity and diabetes, according to the World Health Organization (WHO). The WHO’s newly released Global status report on physical activity 2022 measures the extent to which governments are implementing recommendations to increase physical activity across all ages […] Continue reading -> More Industry Support for Pharma’s Pandemic Vaccine Equity Plan – ‘Not Enough’ says Civil Society 24/10/2022 Kerry Cullinan The Biotechnology Innovation Organization (BIO) and Developing Countries Vaccine Manufacturers’ Network (DCVMN) have thrown their weight behind the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) proposal to improve access to vaccines in future pandemics. The proposal, known as the Berlin Declaration, outlines how the pharmaceutical industry would reserve an allocation of real-time production of […] Continue reading -> Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> Lack of Cancer Detection and Treatment is Driving Deaths in Poorer Countries 19/10/2022 Kerry Cullinan Common cancers that can be treated successfully when they’re detected early – breast, cervical, colorectal and prostate – are causing high mortality in low and middle-income countries (LMICs) because of a lack of screening and treatment, Dr Cary Adams, CEO of the Union for International Cancer Control (UICC), told a press conference at the start […] Continue reading -> World’s Pandemic Response: Tall on Principles But Short on Plans 17/10/2022 Kerry Cullinan Amid criticism that the World Health Summit was ‘speed-dating for consultants’, panellists lamented a lack of practical plans to empower local service delivery A more empowered World Health Organization (WHO), stronger health local systems and better surveillance are some of the weapons that will protect the world against future pandemics, according to panellists at the […] Continue reading -> COVAX, the Global COVID-19 Vaccine Platform, was ‘Too Ambitious’ 14/10/2022 Kerry Cullinan Midway through last year, the head of the Africa Vaccine Acquisition Task Team, Strive Masiyiwa, angrily accused the global COVID-19 vaccine acquisition platform, COVAX, of misleading African countries about its ability to procure vaccines for them. Masiyiwa’s bitter remarks came after months of Africans watching Europeans and North Americans being vaccinated against COVID-19 while no […] Continue reading -> WHO Experts Weigh in on Measles, Monkeypox and COVID Bivalent Vaccines 11/10/2022 Kerry Cullinan Measles outbreaks are escalating in large parts of the world thanks to “backsliding” in national immunisation programmes during the COVID-19 pandemic, the World Health Organization’s (WHO) Strategic Advisory Group of Experts (SAGE) on immunization warned on Tuesday. “There were 25 million children un- or under-vaccinated in 2021,” said Dr Kate O’Brien, WHO’s director of immunization, […] Continue reading -> mRNA Technology is ‘The Answer’ to Sustainable Local Vaccine Production 11/10/2022 Kerry Cullinan If sustainability of vaccine production is the question, then mRNA technology is the answer, Martin Friede, co-ordinator for vaccine research at the World Health Organization (WHO), told a panel convened by the Global Health Centre at the Geneva Graduate Institute on Monday. “The big advantage of mRNA is that, in theory, you can make many […] Continue reading -> Sharp Disagreement Over Intellectual Property at WHO Pandemic Treaty Consultation 08/10/2022 Kerry Cullinan Sharp disagreements emerged about the role of intellectual property (IP) during a pandemic at a panel convened by the World Health Organization (WHO) Intergovernmental Negotiating Body (INB), which is charged with developing a pandemic treaty. Komal Kalha, associate director of IP at the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), insisted that the fast […] Continue reading -> Posts navigation Older postsNewer posts
Countries Fail to Promote Physical Activity; Study Links Exercise and Vaccine Efficacy 25/10/2022 Kerry Cullinan Most countries are failing dismally to promote physical exercise despite inactivity playing a major role in heart disease, obesity and diabetes, according to the World Health Organization (WHO). The WHO’s newly released Global status report on physical activity 2022 measures the extent to which governments are implementing recommendations to increase physical activity across all ages […] Continue reading -> More Industry Support for Pharma’s Pandemic Vaccine Equity Plan – ‘Not Enough’ says Civil Society 24/10/2022 Kerry Cullinan The Biotechnology Innovation Organization (BIO) and Developing Countries Vaccine Manufacturers’ Network (DCVMN) have thrown their weight behind the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) proposal to improve access to vaccines in future pandemics. The proposal, known as the Berlin Declaration, outlines how the pharmaceutical industry would reserve an allocation of real-time production of […] Continue reading -> Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> Lack of Cancer Detection and Treatment is Driving Deaths in Poorer Countries 19/10/2022 Kerry Cullinan Common cancers that can be treated successfully when they’re detected early – breast, cervical, colorectal and prostate – are causing high mortality in low and middle-income countries (LMICs) because of a lack of screening and treatment, Dr Cary Adams, CEO of the Union for International Cancer Control (UICC), told a press conference at the start […] Continue reading -> World’s Pandemic Response: Tall on Principles But Short on Plans 17/10/2022 Kerry Cullinan Amid criticism that the World Health Summit was ‘speed-dating for consultants’, panellists lamented a lack of practical plans to empower local service delivery A more empowered World Health Organization (WHO), stronger health local systems and better surveillance are some of the weapons that will protect the world against future pandemics, according to panellists at the […] Continue reading -> COVAX, the Global COVID-19 Vaccine Platform, was ‘Too Ambitious’ 14/10/2022 Kerry Cullinan Midway through last year, the head of the Africa Vaccine Acquisition Task Team, Strive Masiyiwa, angrily accused the global COVID-19 vaccine acquisition platform, COVAX, of misleading African countries about its ability to procure vaccines for them. Masiyiwa’s bitter remarks came after months of Africans watching Europeans and North Americans being vaccinated against COVID-19 while no […] Continue reading -> WHO Experts Weigh in on Measles, Monkeypox and COVID Bivalent Vaccines 11/10/2022 Kerry Cullinan Measles outbreaks are escalating in large parts of the world thanks to “backsliding” in national immunisation programmes during the COVID-19 pandemic, the World Health Organization’s (WHO) Strategic Advisory Group of Experts (SAGE) on immunization warned on Tuesday. “There were 25 million children un- or under-vaccinated in 2021,” said Dr Kate O’Brien, WHO’s director of immunization, […] Continue reading -> mRNA Technology is ‘The Answer’ to Sustainable Local Vaccine Production 11/10/2022 Kerry Cullinan If sustainability of vaccine production is the question, then mRNA technology is the answer, Martin Friede, co-ordinator for vaccine research at the World Health Organization (WHO), told a panel convened by the Global Health Centre at the Geneva Graduate Institute on Monday. “The big advantage of mRNA is that, in theory, you can make many […] Continue reading -> Sharp Disagreement Over Intellectual Property at WHO Pandemic Treaty Consultation 08/10/2022 Kerry Cullinan Sharp disagreements emerged about the role of intellectual property (IP) during a pandemic at a panel convened by the World Health Organization (WHO) Intergovernmental Negotiating Body (INB), which is charged with developing a pandemic treaty. Komal Kalha, associate director of IP at the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), insisted that the fast […] Continue reading -> Posts navigation Older postsNewer posts
More Industry Support for Pharma’s Pandemic Vaccine Equity Plan – ‘Not Enough’ says Civil Society 24/10/2022 Kerry Cullinan The Biotechnology Innovation Organization (BIO) and Developing Countries Vaccine Manufacturers’ Network (DCVMN) have thrown their weight behind the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) proposal to improve access to vaccines in future pandemics. The proposal, known as the Berlin Declaration, outlines how the pharmaceutical industry would reserve an allocation of real-time production of […] Continue reading -> Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> Lack of Cancer Detection and Treatment is Driving Deaths in Poorer Countries 19/10/2022 Kerry Cullinan Common cancers that can be treated successfully when they’re detected early – breast, cervical, colorectal and prostate – are causing high mortality in low and middle-income countries (LMICs) because of a lack of screening and treatment, Dr Cary Adams, CEO of the Union for International Cancer Control (UICC), told a press conference at the start […] Continue reading -> World’s Pandemic Response: Tall on Principles But Short on Plans 17/10/2022 Kerry Cullinan Amid criticism that the World Health Summit was ‘speed-dating for consultants’, panellists lamented a lack of practical plans to empower local service delivery A more empowered World Health Organization (WHO), stronger health local systems and better surveillance are some of the weapons that will protect the world against future pandemics, according to panellists at the […] Continue reading -> COVAX, the Global COVID-19 Vaccine Platform, was ‘Too Ambitious’ 14/10/2022 Kerry Cullinan Midway through last year, the head of the Africa Vaccine Acquisition Task Team, Strive Masiyiwa, angrily accused the global COVID-19 vaccine acquisition platform, COVAX, of misleading African countries about its ability to procure vaccines for them. Masiyiwa’s bitter remarks came after months of Africans watching Europeans and North Americans being vaccinated against COVID-19 while no […] Continue reading -> WHO Experts Weigh in on Measles, Monkeypox and COVID Bivalent Vaccines 11/10/2022 Kerry Cullinan Measles outbreaks are escalating in large parts of the world thanks to “backsliding” in national immunisation programmes during the COVID-19 pandemic, the World Health Organization’s (WHO) Strategic Advisory Group of Experts (SAGE) on immunization warned on Tuesday. “There were 25 million children un- or under-vaccinated in 2021,” said Dr Kate O’Brien, WHO’s director of immunization, […] Continue reading -> mRNA Technology is ‘The Answer’ to Sustainable Local Vaccine Production 11/10/2022 Kerry Cullinan If sustainability of vaccine production is the question, then mRNA technology is the answer, Martin Friede, co-ordinator for vaccine research at the World Health Organization (WHO), told a panel convened by the Global Health Centre at the Geneva Graduate Institute on Monday. “The big advantage of mRNA is that, in theory, you can make many […] Continue reading -> Sharp Disagreement Over Intellectual Property at WHO Pandemic Treaty Consultation 08/10/2022 Kerry Cullinan Sharp disagreements emerged about the role of intellectual property (IP) during a pandemic at a panel convened by the World Health Organization (WHO) Intergovernmental Negotiating Body (INB), which is charged with developing a pandemic treaty. Komal Kalha, associate director of IP at the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), insisted that the fast […] Continue reading -> Posts navigation Older postsNewer posts
Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> Lack of Cancer Detection and Treatment is Driving Deaths in Poorer Countries 19/10/2022 Kerry Cullinan Common cancers that can be treated successfully when they’re detected early – breast, cervical, colorectal and prostate – are causing high mortality in low and middle-income countries (LMICs) because of a lack of screening and treatment, Dr Cary Adams, CEO of the Union for International Cancer Control (UICC), told a press conference at the start […] Continue reading -> World’s Pandemic Response: Tall on Principles But Short on Plans 17/10/2022 Kerry Cullinan Amid criticism that the World Health Summit was ‘speed-dating for consultants’, panellists lamented a lack of practical plans to empower local service delivery A more empowered World Health Organization (WHO), stronger health local systems and better surveillance are some of the weapons that will protect the world against future pandemics, according to panellists at the […] Continue reading -> COVAX, the Global COVID-19 Vaccine Platform, was ‘Too Ambitious’ 14/10/2022 Kerry Cullinan Midway through last year, the head of the Africa Vaccine Acquisition Task Team, Strive Masiyiwa, angrily accused the global COVID-19 vaccine acquisition platform, COVAX, of misleading African countries about its ability to procure vaccines for them. Masiyiwa’s bitter remarks came after months of Africans watching Europeans and North Americans being vaccinated against COVID-19 while no […] Continue reading -> WHO Experts Weigh in on Measles, Monkeypox and COVID Bivalent Vaccines 11/10/2022 Kerry Cullinan Measles outbreaks are escalating in large parts of the world thanks to “backsliding” in national immunisation programmes during the COVID-19 pandemic, the World Health Organization’s (WHO) Strategic Advisory Group of Experts (SAGE) on immunization warned on Tuesday. “There were 25 million children un- or under-vaccinated in 2021,” said Dr Kate O’Brien, WHO’s director of immunization, […] Continue reading -> mRNA Technology is ‘The Answer’ to Sustainable Local Vaccine Production 11/10/2022 Kerry Cullinan If sustainability of vaccine production is the question, then mRNA technology is the answer, Martin Friede, co-ordinator for vaccine research at the World Health Organization (WHO), told a panel convened by the Global Health Centre at the Geneva Graduate Institute on Monday. “The big advantage of mRNA is that, in theory, you can make many […] Continue reading -> Sharp Disagreement Over Intellectual Property at WHO Pandemic Treaty Consultation 08/10/2022 Kerry Cullinan Sharp disagreements emerged about the role of intellectual property (IP) during a pandemic at a panel convened by the World Health Organization (WHO) Intergovernmental Negotiating Body (INB), which is charged with developing a pandemic treaty. Komal Kalha, associate director of IP at the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), insisted that the fast […] Continue reading -> Posts navigation Older postsNewer posts
Lack of Cancer Detection and Treatment is Driving Deaths in Poorer Countries 19/10/2022 Kerry Cullinan Common cancers that can be treated successfully when they’re detected early – breast, cervical, colorectal and prostate – are causing high mortality in low and middle-income countries (LMICs) because of a lack of screening and treatment, Dr Cary Adams, CEO of the Union for International Cancer Control (UICC), told a press conference at the start […] Continue reading -> World’s Pandemic Response: Tall on Principles But Short on Plans 17/10/2022 Kerry Cullinan Amid criticism that the World Health Summit was ‘speed-dating for consultants’, panellists lamented a lack of practical plans to empower local service delivery A more empowered World Health Organization (WHO), stronger health local systems and better surveillance are some of the weapons that will protect the world against future pandemics, according to panellists at the […] Continue reading -> COVAX, the Global COVID-19 Vaccine Platform, was ‘Too Ambitious’ 14/10/2022 Kerry Cullinan Midway through last year, the head of the Africa Vaccine Acquisition Task Team, Strive Masiyiwa, angrily accused the global COVID-19 vaccine acquisition platform, COVAX, of misleading African countries about its ability to procure vaccines for them. Masiyiwa’s bitter remarks came after months of Africans watching Europeans and North Americans being vaccinated against COVID-19 while no […] Continue reading -> WHO Experts Weigh in on Measles, Monkeypox and COVID Bivalent Vaccines 11/10/2022 Kerry Cullinan Measles outbreaks are escalating in large parts of the world thanks to “backsliding” in national immunisation programmes during the COVID-19 pandemic, the World Health Organization’s (WHO) Strategic Advisory Group of Experts (SAGE) on immunization warned on Tuesday. “There were 25 million children un- or under-vaccinated in 2021,” said Dr Kate O’Brien, WHO’s director of immunization, […] Continue reading -> mRNA Technology is ‘The Answer’ to Sustainable Local Vaccine Production 11/10/2022 Kerry Cullinan If sustainability of vaccine production is the question, then mRNA technology is the answer, Martin Friede, co-ordinator for vaccine research at the World Health Organization (WHO), told a panel convened by the Global Health Centre at the Geneva Graduate Institute on Monday. “The big advantage of mRNA is that, in theory, you can make many […] Continue reading -> Sharp Disagreement Over Intellectual Property at WHO Pandemic Treaty Consultation 08/10/2022 Kerry Cullinan Sharp disagreements emerged about the role of intellectual property (IP) during a pandemic at a panel convened by the World Health Organization (WHO) Intergovernmental Negotiating Body (INB), which is charged with developing a pandemic treaty. Komal Kalha, associate director of IP at the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), insisted that the fast […] Continue reading -> Posts navigation Older postsNewer posts
World’s Pandemic Response: Tall on Principles But Short on Plans 17/10/2022 Kerry Cullinan Amid criticism that the World Health Summit was ‘speed-dating for consultants’, panellists lamented a lack of practical plans to empower local service delivery A more empowered World Health Organization (WHO), stronger health local systems and better surveillance are some of the weapons that will protect the world against future pandemics, according to panellists at the […] Continue reading -> COVAX, the Global COVID-19 Vaccine Platform, was ‘Too Ambitious’ 14/10/2022 Kerry Cullinan Midway through last year, the head of the Africa Vaccine Acquisition Task Team, Strive Masiyiwa, angrily accused the global COVID-19 vaccine acquisition platform, COVAX, of misleading African countries about its ability to procure vaccines for them. Masiyiwa’s bitter remarks came after months of Africans watching Europeans and North Americans being vaccinated against COVID-19 while no […] Continue reading -> WHO Experts Weigh in on Measles, Monkeypox and COVID Bivalent Vaccines 11/10/2022 Kerry Cullinan Measles outbreaks are escalating in large parts of the world thanks to “backsliding” in national immunisation programmes during the COVID-19 pandemic, the World Health Organization’s (WHO) Strategic Advisory Group of Experts (SAGE) on immunization warned on Tuesday. “There were 25 million children un- or under-vaccinated in 2021,” said Dr Kate O’Brien, WHO’s director of immunization, […] Continue reading -> mRNA Technology is ‘The Answer’ to Sustainable Local Vaccine Production 11/10/2022 Kerry Cullinan If sustainability of vaccine production is the question, then mRNA technology is the answer, Martin Friede, co-ordinator for vaccine research at the World Health Organization (WHO), told a panel convened by the Global Health Centre at the Geneva Graduate Institute on Monday. “The big advantage of mRNA is that, in theory, you can make many […] Continue reading -> Sharp Disagreement Over Intellectual Property at WHO Pandemic Treaty Consultation 08/10/2022 Kerry Cullinan Sharp disagreements emerged about the role of intellectual property (IP) during a pandemic at a panel convened by the World Health Organization (WHO) Intergovernmental Negotiating Body (INB), which is charged with developing a pandemic treaty. Komal Kalha, associate director of IP at the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), insisted that the fast […] Continue reading -> Posts navigation Older postsNewer posts
COVAX, the Global COVID-19 Vaccine Platform, was ‘Too Ambitious’ 14/10/2022 Kerry Cullinan Midway through last year, the head of the Africa Vaccine Acquisition Task Team, Strive Masiyiwa, angrily accused the global COVID-19 vaccine acquisition platform, COVAX, of misleading African countries about its ability to procure vaccines for them. Masiyiwa’s bitter remarks came after months of Africans watching Europeans and North Americans being vaccinated against COVID-19 while no […] Continue reading -> WHO Experts Weigh in on Measles, Monkeypox and COVID Bivalent Vaccines 11/10/2022 Kerry Cullinan Measles outbreaks are escalating in large parts of the world thanks to “backsliding” in national immunisation programmes during the COVID-19 pandemic, the World Health Organization’s (WHO) Strategic Advisory Group of Experts (SAGE) on immunization warned on Tuesday. “There were 25 million children un- or under-vaccinated in 2021,” said Dr Kate O’Brien, WHO’s director of immunization, […] Continue reading -> mRNA Technology is ‘The Answer’ to Sustainable Local Vaccine Production 11/10/2022 Kerry Cullinan If sustainability of vaccine production is the question, then mRNA technology is the answer, Martin Friede, co-ordinator for vaccine research at the World Health Organization (WHO), told a panel convened by the Global Health Centre at the Geneva Graduate Institute on Monday. “The big advantage of mRNA is that, in theory, you can make many […] Continue reading -> Sharp Disagreement Over Intellectual Property at WHO Pandemic Treaty Consultation 08/10/2022 Kerry Cullinan Sharp disagreements emerged about the role of intellectual property (IP) during a pandemic at a panel convened by the World Health Organization (WHO) Intergovernmental Negotiating Body (INB), which is charged with developing a pandemic treaty. Komal Kalha, associate director of IP at the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), insisted that the fast […] Continue reading -> Posts navigation Older postsNewer posts
WHO Experts Weigh in on Measles, Monkeypox and COVID Bivalent Vaccines 11/10/2022 Kerry Cullinan Measles outbreaks are escalating in large parts of the world thanks to “backsliding” in national immunisation programmes during the COVID-19 pandemic, the World Health Organization’s (WHO) Strategic Advisory Group of Experts (SAGE) on immunization warned on Tuesday. “There were 25 million children un- or under-vaccinated in 2021,” said Dr Kate O’Brien, WHO’s director of immunization, […] Continue reading -> mRNA Technology is ‘The Answer’ to Sustainable Local Vaccine Production 11/10/2022 Kerry Cullinan If sustainability of vaccine production is the question, then mRNA technology is the answer, Martin Friede, co-ordinator for vaccine research at the World Health Organization (WHO), told a panel convened by the Global Health Centre at the Geneva Graduate Institute on Monday. “The big advantage of mRNA is that, in theory, you can make many […] Continue reading -> Sharp Disagreement Over Intellectual Property at WHO Pandemic Treaty Consultation 08/10/2022 Kerry Cullinan Sharp disagreements emerged about the role of intellectual property (IP) during a pandemic at a panel convened by the World Health Organization (WHO) Intergovernmental Negotiating Body (INB), which is charged with developing a pandemic treaty. Komal Kalha, associate director of IP at the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), insisted that the fast […] Continue reading -> Posts navigation Older postsNewer posts
mRNA Technology is ‘The Answer’ to Sustainable Local Vaccine Production 11/10/2022 Kerry Cullinan If sustainability of vaccine production is the question, then mRNA technology is the answer, Martin Friede, co-ordinator for vaccine research at the World Health Organization (WHO), told a panel convened by the Global Health Centre at the Geneva Graduate Institute on Monday. “The big advantage of mRNA is that, in theory, you can make many […] Continue reading -> Sharp Disagreement Over Intellectual Property at WHO Pandemic Treaty Consultation 08/10/2022 Kerry Cullinan Sharp disagreements emerged about the role of intellectual property (IP) during a pandemic at a panel convened by the World Health Organization (WHO) Intergovernmental Negotiating Body (INB), which is charged with developing a pandemic treaty. Komal Kalha, associate director of IP at the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), insisted that the fast […] Continue reading -> Posts navigation Older postsNewer posts
Sharp Disagreement Over Intellectual Property at WHO Pandemic Treaty Consultation 08/10/2022 Kerry Cullinan Sharp disagreements emerged about the role of intellectual property (IP) during a pandemic at a panel convened by the World Health Organization (WHO) Intergovernmental Negotiating Body (INB), which is charged with developing a pandemic treaty. Komal Kalha, associate director of IP at the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), insisted that the fast […] Continue reading -> Posts navigation Older postsNewer posts